[SCHEDULE 13D/A] Acuren Corporation SEC Filing
Acuren Corporation's Schedule 13D/A reports that Mariposa Acquisition IX, LLC and Sir Martin E. Franklin updated their ownership disclosure after the transactions contemplated by a Merger Agreement were completed. The amendment states that the issuance of Common Stock in connection with the Merger increased the number of shares outstanding and, solely for that reason, reduced the Reporting Persons' percentage ownership.
The Reporting Persons now beneficially own 19,877,500 shares of Common Stock, representing 9.86% of the class, based on 200,598,758 shares of Common Stock and 1,000,000 shares of Series A Preferred Stock outstanding following the Merger. The Voting Agreement among the parties automatically terminated upon approval of the Acuren stock issuance at the Annual Meeting. The filing also incorporates several agreements as exhibits, including the Joint Filing Agreement, Placing Agreement and Voting Support Agreement.
Il Schedule 13D/A di Acuren Corporation segnala che Mariposa Acquisition IX, LLC e Sir Martin E. Franklin hanno aggiornato la loro comunicazione sulla partecipazione azionaria dopo il completamento delle operazioni previste dall'Accordo di Fusione. L'emendamento specifica che l'emissione di Azioni Ordinarie in relazione alla Fusione ha aumentato il numero di azioni in circolazione e, unicamente per tale motivo, ha ridotto la percentuale di partecipazione delle persone segnalanti.
Le persone segnalanti ora possiedono utilmente 19,877,500 azioni ordinarie, rappresentanti 9.86% della classe, calcolato su 200,598,758 azioni ordinarie e 1,000,000 azioni di Serie A Preferred in circolazione dopo la Fusione. L'Accordo di Voto tra le parti si è automaticamente risolto all'approvazione dell'emissione di azioni di Acuren durante l'Assemblea Annuale. Il deposito include inoltre come allegati diversi accordi, tra cui il Joint Filing Agreement, il Placing Agreement e il Voting Support Agreement.
El Schedule 13D/A de Acuren Corporation informa que Mariposa Acquisition IX, LLC y Sir Martin E. Franklin actualizaron su declaración de participación tras completarse las operaciones contempladas en el Acuerdo de Fusión. La enmienda señala que la emisión de Acciones Ordinarias en relación con la Fusión incrementó el número de acciones en circulación y, únicamente por esa razón, redujo el porcentaje de propiedad de las Personas Informantes.
Las Personas Informantes ahora poseen de forma beneficiaria 19,877,500 acciones Ordinarias, que representan 9.86% de la clase, con base en 200,598,758 acciones Ordinarias y 1,000,000 acciones de la Serie A Preferred en circulación tras la Fusión. El Acuerdo de Votación entre las partes terminó automáticamente al aprobarse la emisión de acciones de Acuren en la Junta Anual. La presentación incorpora además varios acuerdos como anexos, incluidos el Joint Filing Agreement, el Placing Agreement y el Voting Support Agreement.
Acuren Corporation의 Schedule 13D/A는 Mariposa Acquisition IX, LLC와 Sir Martin E. Franklin이 합병 계약에서 예정된 거래들이 완료된 후 소유권 공개를 갱신했다고 보고합니다. 수정서는 합병과 관련된 보통주 발행으로 발행 주식 수가 증가했으며, 오직 그 이유로 보고인의 지분 비율이 감소했다고 명시합니다.
보고인은 현재 실질적으로 19,877,500주의 보통주를 보유하고 있으며, 이는 해당 종목의 9.86%에 해당합니다. 이는 합병 후 보통주 200,598,758주와 시리즈 A 우선주 1,000,000주가 유통된 것을 기준으로 산출된 수치입니다. 당사자들 간의 의결권 계약은 연례총회에서 Acuren 주식 발행 승인이 이루어짐에 따라 자동으로 종료되었습니다. 제출 서류에는 Joint Filing Agreement, Placing Agreement 및 Voting Support Agreement를 포함한 여러 계약이 증거서류로 첨부되어 있습니다.
Le Schedule 13D/A d'Acuren Corporation indique que Mariposa Acquisition IX, LLC et Sir Martin E. Franklin ont mis à jour leur déclaration de détention après la réalisation des opérations prévues par l'Accord de Fusion. L'amendement précise que l'émission d'actions ordinaires liée à la fusion a augmenté le nombre d'actions en circulation et, uniquement pour cette raison, a réduit le pourcentage de participation des personnes déclarantes.
Les personnes déclarantes détiennent désormais à titre bénéficiaire 19,877,500 actions ordinaires, représentant 9.86% de la catégorie, sur la base de 200,598,758 actions ordinaires et 1,000,000 actions de Series A Preferred en circulation suite à la fusion. L'accord de vote entre les parties a pris fin automatiquement lors de l'approbation de l'émission d'actions d'Acuren à l'Assemblée annuelle. Le dossier comporte également plusieurs accords en annexes, notamment le Joint Filing Agreement, le Placing Agreement et le Voting Support Agreement.
Der Schedule 13D/A von Acuren Corporation berichtet, dass Mariposa Acquisition IX, LLC und Sir Martin E. Franklin ihre Offenlegung der Eigentumsverhältnisse aktualisiert haben, nachdem die im Fusionsvertrag vorgesehenen Transaktionen abgeschlossen wurden. Die Änderung stellt fest, dass die im Zusammenhang mit der Fusion erfolgte Ausgabe von Stammaktien die Anzahl der ausstehenden Aktien erhöht und ausschließlich aus diesem Grund den prozentualen Eigentumsanteil der berichtenden Personen verringert hat.
Die berichtenden Personen besitzen nun wirtschaftlich 19,877,500 Stammaktien, was 9.86% der Klasse entspricht, basierend auf 200,598,758 ausstehenden Stammaktien und 1,000,000 ausstehenden Aktien der Series A Preferred nach der Fusion. Die zwischen den Parteien geschlossene Stimmrechtsvereinbarung endete automatisch mit der Genehmigung der Acuren-Aktienausgabe auf der Hauptversammlung. Die Einreichung enthält außerdem mehrere Vereinbarungen als Anlagen, darunter das Joint Filing Agreement, das Placing Agreement und das Voting Support Agreement.
- Transparent update of ownership following the Merger, including precise share counts used to calculate the stake
- Substantial beneficial holding of 19,877,500 shares disclosed, representing 9.86% of the outstanding Common Stock
- Percentage ownership decreased for the Reporting Persons due solely to issuance of additional Common Stock by the Issuer
- Voting Agreement terminated upon approval of the stock issuance, ending previously disclosed voting arrangements
Insights
TL;DR: Mariposa/Franklin hold 19.88M Acuren shares (9.86%) after merger-related issuance; ownership percentage fell due to share issuance.
The amendment confirms completion of the Merger Agreement transactions and that the Reporting Persons' percentage ownership was reduced solely because the Issuer issued additional Common Stock. The filing provides updated share counts used to calculate the 9.86% stake and clarifies that dividends and sale proceeds rights remain with the Reporting Persons. For investors, the disclosure updates the ownership baseline but does not assert any new purchases or sales by the Reporting Persons.
TL;DR: Disclosure shows a near-10% ownership stake and that the previously effective Voting Agreement terminated following shareholder approval of the stock issuance.
The Schedule 13D/A notes that the Voting Agreement automatically terminated upon approval of the Acuren stock issuance at the Annual Meeting, altering the contractual governance arrangements described in earlier filings. The filing also references the Voting Support Agreement and other contracts as exhibits, providing the documentary basis for prior coordination. This is a material governance update for stakeholders tracking shareholder alignment and contractual voting support.
Il Schedule 13D/A di Acuren Corporation segnala che Mariposa Acquisition IX, LLC e Sir Martin E. Franklin hanno aggiornato la loro comunicazione sulla partecipazione azionaria dopo il completamento delle operazioni previste dall'Accordo di Fusione. L'emendamento specifica che l'emissione di Azioni Ordinarie in relazione alla Fusione ha aumentato il numero di azioni in circolazione e, unicamente per tale motivo, ha ridotto la percentuale di partecipazione delle persone segnalanti.
Le persone segnalanti ora possiedono utilmente 19,877,500 azioni ordinarie, rappresentanti 9.86% della classe, calcolato su 200,598,758 azioni ordinarie e 1,000,000 azioni di Serie A Preferred in circolazione dopo la Fusione. L'Accordo di Voto tra le parti si è automaticamente risolto all'approvazione dell'emissione di azioni di Acuren durante l'Assemblea Annuale. Il deposito include inoltre come allegati diversi accordi, tra cui il Joint Filing Agreement, il Placing Agreement e il Voting Support Agreement.
El Schedule 13D/A de Acuren Corporation informa que Mariposa Acquisition IX, LLC y Sir Martin E. Franklin actualizaron su declaración de participación tras completarse las operaciones contempladas en el Acuerdo de Fusión. La enmienda señala que la emisión de Acciones Ordinarias en relación con la Fusión incrementó el número de acciones en circulación y, únicamente por esa razón, redujo el porcentaje de propiedad de las Personas Informantes.
Las Personas Informantes ahora poseen de forma beneficiaria 19,877,500 acciones Ordinarias, que representan 9.86% de la clase, con base en 200,598,758 acciones Ordinarias y 1,000,000 acciones de la Serie A Preferred en circulación tras la Fusión. El Acuerdo de Votación entre las partes terminó automáticamente al aprobarse la emisión de acciones de Acuren en la Junta Anual. La presentación incorpora además varios acuerdos como anexos, incluidos el Joint Filing Agreement, el Placing Agreement y el Voting Support Agreement.
Acuren Corporation의 Schedule 13D/A는 Mariposa Acquisition IX, LLC와 Sir Martin E. Franklin이 합병 계약에서 예정된 거래들이 완료된 후 소유권 공개를 갱신했다고 보고합니다. 수정서는 합병과 관련된 보통주 발행으로 발행 주식 수가 증가했으며, 오직 그 이유로 보고인의 지분 비율이 감소했다고 명시합니다.
보고인은 현재 실질적으로 19,877,500주의 보통주를 보유하고 있으며, 이는 해당 종목의 9.86%에 해당합니다. 이는 합병 후 보통주 200,598,758주와 시리즈 A 우선주 1,000,000주가 유통된 것을 기준으로 산출된 수치입니다. 당사자들 간의 의결권 계약은 연례총회에서 Acuren 주식 발행 승인이 이루어짐에 따라 자동으로 종료되었습니다. 제출 서류에는 Joint Filing Agreement, Placing Agreement 및 Voting Support Agreement를 포함한 여러 계약이 증거서류로 첨부되어 있습니다.
Le Schedule 13D/A d'Acuren Corporation indique que Mariposa Acquisition IX, LLC et Sir Martin E. Franklin ont mis à jour leur déclaration de détention après la réalisation des opérations prévues par l'Accord de Fusion. L'amendement précise que l'émission d'actions ordinaires liée à la fusion a augmenté le nombre d'actions en circulation et, uniquement pour cette raison, a réduit le pourcentage de participation des personnes déclarantes.
Les personnes déclarantes détiennent désormais à titre bénéficiaire 19,877,500 actions ordinaires, représentant 9.86% de la catégorie, sur la base de 200,598,758 actions ordinaires et 1,000,000 actions de Series A Preferred en circulation suite à la fusion. L'accord de vote entre les parties a pris fin automatiquement lors de l'approbation de l'émission d'actions d'Acuren à l'Assemblée annuelle. Le dossier comporte également plusieurs accords en annexes, notamment le Joint Filing Agreement, le Placing Agreement et le Voting Support Agreement.
Der Schedule 13D/A von Acuren Corporation berichtet, dass Mariposa Acquisition IX, LLC und Sir Martin E. Franklin ihre Offenlegung der Eigentumsverhältnisse aktualisiert haben, nachdem die im Fusionsvertrag vorgesehenen Transaktionen abgeschlossen wurden. Die Änderung stellt fest, dass die im Zusammenhang mit der Fusion erfolgte Ausgabe von Stammaktien die Anzahl der ausstehenden Aktien erhöht und ausschließlich aus diesem Grund den prozentualen Eigentumsanteil der berichtenden Personen verringert hat.
Die berichtenden Personen besitzen nun wirtschaftlich 19,877,500 Stammaktien, was 9.86% der Klasse entspricht, basierend auf 200,598,758 ausstehenden Stammaktien und 1,000,000 ausstehenden Aktien der Series A Preferred nach der Fusion. Die zwischen den Parteien geschlossene Stimmrechtsvereinbarung endete automatisch mit der Genehmigung der Acuren-Aktienausgabe auf der Hauptversammlung. Die Einreichung enthält außerdem mehrere Vereinbarungen als Anlagen, darunter das Joint Filing Agreement, das Placing Agreement und das Voting Support Agreement.
FAQ
What stake does Mariposa Acquisition IX, LLC and Sir Martin E. Franklin hold in Acuren (TIC)?
Why did the Reporting Persons' percentage ownership change in the Schedule 13D/A for TIC?
Does the filing say the Voting Agreement is still in effect for Acuren (TIC)?
What share totals were used to calculate the 9.86% ownership in TIC?
What supporting documents are attached or incorporated in the Schedule 13D/A for TIC?
